Stereotaxis

Stereotaxis to acquire Robocath for up to $45M

Stereotaxis announced an agreement to acquire surgical robotics company Robocath for up to $45 million. The deal includes a $20 million upfront payment with an additional $25 million tied to milestones such as FDA clearance of Robocath's next-generation robotic platform, which has already completed a first-in-human trial.